Neuropharmacological studies on ethyl acetate fraction of Securinega virosa root bark extract

Abstract

This study was conducted to evaluate the neuropharmacological activities of the ethyl acetate fraction of methanol root bark extract of Securinega virosa using in vivo models in laboratory animals. The fraction (125, 250 and 500 mg/kg) did not protect the animals against tonic hind limb extension induced by electroshock but produced a dose-dependently protection of animals against clonic spasm induced by pentylenetetrazole, with the highest protection of 66.67% produced by the highest dose tested. The fraction significantly (P < 0.01) and dose-dependently decreased the mean latency to sleep and increased mean sleep duration in mice treated with ketamine. However, it did not significantly increase the number of foot slips in the beam walking assay. These findings suggest that the ethyl acetate fraction of Securinega virosa root bark contains bioactive principle (s) that possesses sedative and anticonvulsant activities.

Medicinal plants used for the management of respiratory diseases in Zimbabwe: Review and perspectives potential management of COVID-19

“… Safe LD 50 > 10000 mg/kg in rats. LD 50 range of 20000–50000 mg/kg body weight Tatematsu et al (1991) ; Moshi et al (2000) ; Magaji et al (2007 , 2008a , b) ; Tanko et al (2008) ; Sanogo et al (2009) ; Yerima et al (2009) ; Aiyelero et al (2012) ; Garba et al (2013 , 2015) ; Abere et al (2014) ; Sempombe et al (2014) ; Zhang et al (2015) ; Shehu et al (2017) ; Ahmad et al (2018) ; Ajaib and Wahla (2018) ; Renu et al (2018) ; Misonge et al (2019) ; Salawu et al (2019) Euphorbiaceae Margaritaria discoidea (Baill.) Webster var.…”